Abstract
Few studies have assessed the risk of adverse pregnancy outcomes in women with multiple sclerosis (MS). We used 2 large US administrative databases, the Truven Health MarketScan Database (2011-2015; Truven Health Analytics Inc., Ann Arbor, Michigan) and the Nationwide Inpatient Sample (2007-2011), to identify delivery cohorts. MS and pregnancy outcomes (infections, cesarean delivery, preterm delivery, poor fetal growth, preeclampsia, chorioamnionitis, postpartum hemorrhage, stillbirth, and infant malformations) were identified during pregnancy and at delivery. We calculated adjusted risk ratios according to MS status and relapse(s) in the year before delivery. Among over 5 million pregnancies, we identified 3,875 pregnancies in women with MS. Women with MS had an increased risk of infections during pregnancy (Truven Health: adjusted risk ratio (aRR) = 1.22, 95% confidence interval (CI): 1.16, 1.27) and preterm delivery (Truven Health: aRR = 1.19 (95% CI: 1.04, 1.35); Nationwide Inpatient Sample: aRR = 1.30 (95% CI: 1.16, 1.44)). The risks of other outcomes were similar for women with and without MS. In the Truven Health database, risk ratios for the pregnancy outcomes in women experiencing relapses versus those without relapses...Continue Reading
References
Feb 1, 1995·Brain : a Journal of Neurology·B Runmarker, O Andersen
Mar 21, 2002·American Journal of Obstetrics and Gynecology·Beth A MuellerCathy W Critchlow
Jun 12, 2003·Birth Defects Research. Part A, Clinical and Molecular Teratology·Sonja A RasmussenUNKNOWN National Birth Defects Prevention Study
Jun 30, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Simone FerreroNicola Ragni
Dec 29, 2005·Neurology·J DahlN E Gilhus
Apr 28, 2006·Acta Neurologica Scandinavica. Supplementum·J DahlN E Gilhus
Jul 19, 2006·Journal of Rehabilitation Research and Development·William J CulpepperDouglas D Bradham
Oct 21, 2006·Lancet Neurology·Sarah-Michelle OrtonUNKNOWN Canadian Collaborative Study Group
Aug 11, 2007·Maternal and Child Health Journal·Elena V KuklinaPolly A Marchbanks
Feb 20, 2008·Journal of Neurology·Julie DahlNils Erik Gilhus
Feb 24, 2009·Journal of Clinical Epidemiology·Peter C Austin
Mar 21, 2009·Multiple Sclerosis : Clinical and Laboratory Research·N Fernández LiguoriA Villa
Mar 26, 2009·Multiple Sclerosis : Clinical and Laboratory Research·Y H ChenH C Lin
Aug 21, 2009·Multiple Sclerosis : Clinical and Laboratory Research·C Weber-Schoendorfer, C Schaefer
Nov 20, 2009·Neurology·Victoria M KellyEliza F Chakravarty
Jan 15, 2010·Neurology·R A MarrieL Elliott
Jun 15, 2010·Multiple Sclerosis : Clinical and Laboratory Research·A JalkanenUNKNOWN Finnish Multiple Sclerosis and Pregnancy Study Group
Oct 5, 2010·Journal of Medical Economics·Benjamin J ChastekMaria V Lopez-Bresnahan
Mar 1, 2011·Autoimmunity Reviews·Johann SellnerOlaf Stüve
Jun 29, 2011·Annals of Neurology·Mia L van der KopHelen Tremlett
Jan 11, 2013·Neurology·Ellen LuUNKNOWN British Columbia Multiple Sclerosis Clinic Neurologists
Feb 7, 2013·Multiple Sclerosis : Clinical and Laboratory Research·E LuUNKNOWN British Columbia Multiple Sclerosis Clinic Neurologists
May 2, 2013·Clinical Obstetrics and Gynecology·Maria Houtchens
Jul 19, 2013·Journal of Neurology·Ellen LuHelen Tremlett
Dec 25, 2013·Journal of Autism and Developmental Disorders·Ousseny ZerboLisa A Croen
Apr 18, 2014·Pharmacoepidemiology and Drug Safety·Kristin PalmstenSonia Hernández-Díaz
Nov 22, 2014·Obstetrics and Gynecology·Riley BoveA Dessa Sadovnick
Jul 7, 2015·JAMA Neurology·Sarah C MacDonaldSonia Hernández-Díaz
Aug 20, 2016·JAMA Psychiatry·Krista F HuybrechtsBrian T Bateman
Nov 29, 2016·Birth Defects Research. Part A, Clinical and Molecular Teratology·Elizabeth C AilesSuzanne M Gilboa
Feb 1, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Alex FongDotun A Ogunyemi
Mar 24, 2018·Paediatric and Perinatal Epidemiology·Sarah C MacDonaldSonia Hernández-Díaz
Citations
May 11, 2019·Pharmacoepidemiology and Drug Safety·Krista F HuybrechtsSonia Hernández-Díaz
Nov 22, 2019·Journal of Women's Health·Mekhala V DissanayakeWilli Horner-Johnson
Jan 25, 2020·Medicina·Guoda VarytėAudronė Arlauskienė
May 7, 2020·Neurodegenerative Disease Management·Galina VorobeychikAshley Cox
Jun 11, 2020·Expert Opinion on Pharmacotherapy·Johanna B Andersen, Melinda Magyari
Aug 18, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giulia MallucciArsenio Spinillo
Apr 24, 2019·Biomedicines·Kelly Tisovic, Lilyana Amezcua
Aug 3, 2020·Journal of Molecular Neuroscience : MN·Niyousha SadeghpourVahid Shaygannejad
Nov 7, 2019·The International Journal of Behavioral Nutrition and Physical Activity·Joshua PetimarJason P Block
Nov 21, 2020·Journal of Women's Health·Caroline SignoreAlison N Cernich
Nov 26, 2019·Neurologic Clinics·Dara G Jamieson, Jennifer W McVige
Feb 11, 2021·Journal of Comparative Effectiveness Research·Pedro J ModregoLeyre Diaz de Cerio
Feb 13, 2021·Obstetrics and Gynecology Clinics of North America·Dara G Jamieson, Jennifer W McVige
Feb 13, 2021·Trends in Molecular Medicine·Camilo EspinosaUNKNOWN Prematurity Research Center at Stanford
Apr 22, 2021·Multiple Sclerosis and Related Disorders·Sofia ColaceciAngela Giusti
May 18, 2021·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·Ahmed ArafaEhab S Eshak